Foley Mark J

Foley Mark J is listed in filings as Director at Glaukos Corporation. This profile follows SEC Form 4 activity through Jun 1, 2026, including sale activity. Recent filings connect the profile to Glaukos Corporation (GKOS) and Revance Therapeutics, Inc. - Common Stock (RVNC). The current snapshot covers public activity from Jul 2, 2024 to Jun 1, 2026. Reported amounts are shown as $160.0K to $2.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.